Great write up Scooter but my god how bad would it be politically right now for an American company to get approval overseas. It would amplify the FDA issues 10 fold.
BTW, has anyone thought about the fact that the HIV approval got "pushed," as M/M was beginning to show great promise. Anyone else think that maybe they didn't want there to be a competitive demand for anything other than COVID? Anyone think last Sunday was possibly intentional on the part of the WH. Does the FDA usually get called out for bungling approvals multiple times in a week? Test Run?
and no im not crazy etc, just enjoying a little vino on a lazy saturday lol
Are we sure that we stayed above $3.00? On 8/19, it looks like we closed at $3.00. I'm pretty sure the metric that NASDAQ uses is the closing bid price. I don't see historical bid/ask pricing data on my platform. Does anyone else know if the bid was $3.00 at the closing on 8/19? Too close for comfort...